Free Trial

Moderna (MRNA) News Today

→ Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad)
Free MRNA Stock Alerts
$149.56
-5.13 (-3.32%)
(As of 02:50 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 7 at 3:03 PM | prnewswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
June 7 at 3:03 PM | prnewswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
June 7 at 9:38 AM | marketbeat.com
Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Pinebridge Investments L.P.
Pinebridge Investments L.P. raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 22.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 56,993 shares of the company's stock after acquiring an addi
June 6 at 10:39 PM | marketbeat.com
Cibc World Markets Corp Increases Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)
Cibc World Markets Corp boosted its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 56.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 97,211 shares of the company's stock after purchasing an additional 35,154 shares during the period. C
June 6 at 8:46 PM | seekingalpha.com
Moderna, Inc. (MRNA) Jefferies 2024 Global Healthcare Conference (Transcript)
June 5 at 5:37 PM | investorplace.com
Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential
June 5 at 5:19 PM | globenewswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
June 5 at 6:56 AM | marketbeat.com
Bank of Nova Scotia Has $4.55 Million Position in Moderna, Inc. (NASDAQ:MRNA)
Bank of Nova Scotia boosted its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 68.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 45,800 shares of the company's stock after buying an additional 18,574
June 4 at 10:56 PM | marketbeat.com
Belpointe Asset Management LLC Boosts Holdings in Moderna, Inc. (NASDAQ:MRNA)
Belpointe Asset Management LLC raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 101.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,265 shares of the company's stock after p
June 4 at 1:22 PM | seekingalpha.com
Moderna, Inc. (MRNA) Moderna Oncology Investor Event (Transcript)
June 4 at 4:28 AM | americanbankingnews.com
Moderna (NASDAQ:MRNA) Receives "Hold" Rating from Needham & Company LLC
June 4 at 3:34 AM | americanbankingnews.com
Moderna (NASDAQ:MRNA) Price Target Raised to $160.00
June 3, 2024 | insidermonkey.com
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
June 3, 2024 | marketbeat.com
Lingotto Investment Management LLP Has $23.18 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)
Lingotto Investment Management LLP boosted its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 75.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 233,095 shares of the company's stock after acquiri
June 3, 2024 | businesswire.com
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
June 3, 2024 | proactiveinvestors.com
Moderna cancer vaccine's potential revealed in phase II data
June 3, 2024 | cnbc.com
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
June 3, 2024 | reuters.com
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
June 3, 2024 | marketbeat.com
Needham & Company LLC Reiterates "Hold" Rating for Moderna (NASDAQ:MRNA)
Needham & Company LLC restated a "hold" rating on shares of Moderna in a research note on Monday.
June 3, 2024 | fool.com
Is Moderna Stock a Buy Now That It's a 2-Product Company?
June 3, 2024 | americanbankingnews.com
Insider Selling: Moderna, Inc. (NASDAQ:MRNA) Director Sells $2,901,600.00 in Stock
June 3, 2024 | fool.com
Moderna Investors Just Got Some Bullish News
June 2, 2024 | marketbeat.com
Focus Financial Network Inc. ADV Purchases Shares of 5,997 Moderna, Inc. (NASDAQ:MRNA)
Focus Financial Network Inc. ADV acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 5,997 shares of the company's stock
June 1, 2024 | marketbeat.com
Alberta Investment Management Corp Acquires 9,900 Shares of Moderna, Inc. (NASDAQ:MRNA)
Alberta Investment Management Corp boosted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 11.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,725 shares o
June 1, 2024 | insidertrades.com
Noubar Afeyan Sells 20,000 Shares of Moderna, Inc. (NASDAQ:MRNA) Stock
June 1, 2024 | insidertrades.com
Stephen Hoge Sells 341 Shares of Moderna, Inc. (NASDAQ:MRNA) Stock
May 31, 2024 | seekingalpha.com
Moderna, Inc. (MRNA) Bernstein's 40th Annual Strategic Decisions Conference (Transcript)
May 31, 2024 | investors.com
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
May 31, 2024 | cnbc.com
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
May 31, 2024 | reuters.com
US FDA approves Moderna's RSV vaccine, its second marketed product
May 31, 2024 | investorplace.com
3 Sorry Biotech Stocks to Sell in May While You Still Can
May 30, 2024 | marketbeat.com
Moderna, Inc. (NASDAQ:MRNA) President Stephen Hoge Sells 341 Shares
Moderna, Inc. (NASDAQ:MRNA - Get Free Report) President Stephen Hoge sold 341 shares of Moderna stock in a transaction that occurred on Wednesday, May 29th. The stock was sold at an average price of $144.50, for a total transaction of $49,274.50. Following the completion of the transaction, the president now owns 1,471,777 shares in the company, valued at approximately $212,671,776.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
May 30, 2024 | fool.com
Why Moderna Stock Is Sinking This Week
May 30, 2024 | americanbankingnews.com
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
May 30, 2024 | investors.com
Moderna Pops After Confirming The U.S. Government Could Back Its Bird Flu Vaccine
May 30, 2024 | americanbankingnews.com
Moderna, Inc. (NASDAQ:MRNA) Insider Shannon Thyme Klinger Sells 1,296 Shares of Stock
May 30, 2024 | americanbankingnews.com
Moderna, Inc. (NASDAQ:MRNA) CFO James M. Mock Sells 648 Shares
May 30, 2024 | insidertrades.com
Moderna, Inc. (NASDAQ:MRNA) CFO Sells $105,280.56 in Stock
May 30, 2024 | marketbeat.com
Advisory Services Network LLC Buys 5,667 Shares of Moderna, Inc. (NASDAQ:MRNA)
Advisory Services Network LLC raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 80.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,715 shares of the company's stock after buying an additional 5,667 share
May 30, 2024 | investorplace.com
3 Nasdaq Stocks to Dump as They Near Peak Performance
May 30, 2024 | reuters.com
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
May 29, 2024 | marketbeat.com
Insider Selling: Moderna, Inc. (NASDAQ:MRNA) CFO Sells $105,280.56 in Stock
Moderna, Inc. (NASDAQ:MRNA - Get Free Report) CFO James M. Mock sold 648 shares of the business's stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $162.47, for a total value of $105,280.56. Following the completion of the sale, the chief financial officer now owns 5,726 shares of the company's stock, valued at $930,303.22. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
May 29, 2024 | ca.news.yahoo.com
Article reported on rising cancer rates before pandemic, didn't link to vaccines | Fact check
May 29, 2024 | finance.yahoo.com
mRNA Therapeutics Market Report 2024-2030: A Projected $31.3 Billion Opportunity Dominated by Moderna, BioNTech, and CureVac
May 29, 2024 | investorplace.com
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
May 28, 2024 | barrons.com
Moderna Shares Had a Bad Day. Here's Why.
May 28, 2024 | marketbeat.com
Edmond DE Rothschild Holding S.A. Sells 12,149 Shares of Moderna, Inc. (NASDAQ:MRNA)
Edmond DE Rothschild Holding S.A. lessened its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 10.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 109,363 shares of the company's stock after selling 12,149 shar
May 28, 2024 | marketbeat.com
Moderna (NASDAQ:MRNA) Shares Down 6.2%
Moderna (NASDAQ:MRNA) Shares Down 6.2%
May 28, 2024 | americanbankingnews.com
Zacks Research Weighs in on Moderna, Inc.'s Q2 2024 Earnings (NASDAQ:MRNA)
May 27, 2024 | marketbeat.com
Intech Investment Management LLC Sells 77,684 Shares of Moderna, Inc. (NASDAQ:MRNA)
Intech Investment Management LLC cut its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 75.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 25,196 shares of the company's
Get Moderna News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter.

What Nvidia insiders don’t want you to know (Ad)

If you missed out on Nvidia, don't worry. A 244-year-old pattern is about to trigger a $25.6 trillion AI surge... And send three overlooked stocks soaring 1,000%+

Get my new research on all three plays right now.

MRNA Media Mentions By Week

MRNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MRNA
News Sentiment
▼
0.61

0.73
▲
Average
Medical
News Sentiment

MRNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MRNA Articles
This Week
▼
30

19
▲
MRNA Articles
Average Week

Get Moderna News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:MRNA) was last updated on 6/7/2024 by MarketBeat.com Staff

From Our Partners
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
Elon Musk’s Final Masterpiece: “X-9840”
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...
Paradigm Press | Sponsored
What Nvidia insiders don’t want you to know
If you missed out on Nvidia, don't worry. A 244-year-old pattern is about to trigger a $25.6 trillion AI surge...
Behind the Markets | Sponsored
Breaking - The US Gov. Seized CITGO
Do you want an investment that can double or triple your money in the next three months? The US Court is cu...
Augury Research | Sponsored
He Is Giving Away Bitcoin
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...
Crypto Swap Profits | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored